Related Experiment Video
Updated: Jul 2, 2026
07:02
Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy
Published on: September 9, 2020
Resveratrol exerts pharmacological preconditioning by activating PGC-1alpha
Lan Tan1, Jin-Tai Yu, Hua-Shi Guan
1College of Medicine and Pharmaceutics, Ocean University of China, Qingdao 266003, Shandong Province, PR China. dr.tanlan@163.com
Medical Hypotheses
|August 13, 2008
Summary
Resveratrol (RSV) may protect organs from ischemic injury by activating Peroxisome proliferators-activated receptor gamma co-activator-1alpha (PGC-1alpha). This research explores RSV
Area of Science:
- Cardiovascular Science
- Nephrology
- Neuroscience
- Molecular Biology
Background:
- Resveratrol (RSV), a natural polyphenol, is investigated for its protective effects against ischemic injury in vital organs.
- The precise molecular mechanisms underlying RSV's pharmacological preconditioning effects are not fully understood.
- Existing research suggests RSV acts as an antioxidant, anti-inflammatory agent, and influences nitric oxide synthase (NOS), angiogenesis, and sirtuin 1 (SIRT1) activity.
Purpose of the Study:
- To investigate the hypothesis that Resveratrol (RSV) exerts its pharmacological preconditioning effects by activating Peroxisome proliferators-activated receptor gamma co-activator-1alpha (PGC-1alpha).
- To elucidate the molecular pathways involved in RSV-mediated protection against ischemia/reperfusion injury.
- To explore novel therapeutic strategies for mitigating organ damage from ischemia/reperfusion.
Main Methods:
- Literature review and synthesis of current research on Resveratrol (RSV) and its molecular targets.
- Analysis of signaling pathways influenced by RSV, focusing on their interaction with PGC-1alpha.
- Evaluation of evidence supporting RSV's role in activating PGC-1alpha.
Main Results:
- RSV exhibits antioxidant, anti-inflammatory, and NOS-inducing properties, alongside effects on angiogenesis and SIRT1 activity.
- Peroxisome proliferators-activated receptor gamma co-activator-1alpha (PGC-1alpha) is a key regulator of mitochondrial biogenesis, antioxidation, and angiogenesis.
- Evidence indicates that RSV can increase PGC-1alpha activity, and many pathways modulated by RSV involve PGC-1alpha.
Conclusions:
- The findings strongly support the hypothesis that Resveratrol (RSV) mediates pharmacological preconditioning through the activation of PGC-1alpha.
- Targeting the RSV-PGC-1alpha pathway offers a promising new direction for developing treatments for ischemia/reperfusion injury.
- Further research confirming this mechanism could lead to novel therapeutic approaches for organ protection.
Related Concept Videos
01:12GPCR Desensitization
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
01:09GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:28Global Regulatory Systems
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
01:31Transducer Mechanism: Nuclear Receptors
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes: